ORMP
Oramed Pharmaceuticals Inc. · Healthcare
Director Kevin Rakin sold $443K of Oramed Pharmaceuticals Inc.
Sold$442,830
$20.99Price
21,100Shares
−27%Stake
What ORMP did after the filing
- The stock from Mon, Sep 20 close, $17.87
- +30.8%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Nov 1 close.
Traded Thu, Sep 16. Filed Mon, Sep 20, 12:01 PM ET, during the session. Returns use the Sep 20 close and the Nov 1 close. Not investment advice.